23andMe and FDA make significant progress in direct-to-consumer testing.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Tel Aviv University researcher identifies novel genetic mutations through DNA sequencing of afflicted child and family.
UC Berkeley & UC San Francisco launch gene-editing initiative.
Merck join the SGC with multi-million dollar contribution. Merck have announced a contribution of C$7.5 million to the Structural Genomics Consortium (SGC), joining as a member organisation. The supported project focus on per-competitive research to develop small inhibitory molecules called chemical probes to study epigenetic mechanisms of regulation. In collaboration with leading clinical institutions in […]
The long battle over BRCA1 and BRCA2 patent infringement finally comes to an end.
Roche are planning on spending $1 billion to take majority control of Foundation Medicine.
Illumina step up their healthcare plans with Lockheed Martin collaboration.